Literature DB >> 25265460

Pretransplantation fluorine-18-deoxyglucose-positron emission tomography scan has no influence on relapse and survival in non-Hodgkin lymphoma patients undergoing allo-SCT.

V Bachanova1, Q Cao2, C Ustun1, A T K Kendi2, J Froelich3, A Lazaryan1, L J Burns1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25265460      PMCID： PMC4753777          DOI： 10.1038/bmt.2014.211

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  10 in total

1.  An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.

Authors:  A J Peniket; M C Ruiz de Elvira; G Taghipour; C Cordonnier; E Gluckman; T de Witte; G Santini; D Blaise; H Greinix; A Ferrant; J Cornelissen; N Schmitz; A H Goldstone
Journal:  Bone Marrow Transplant       Date:  2003-04       Impact factor: 5.483

2.  Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma.

Authors:  Malik E Juweid; Sigrid Stroobants; Otto S Hoekstra; Felix M Mottaghy; Markus Dietlein; Ali Guermazi; Gregory A Wiseman; Lale Kostakoglu; Klemens Scheidhauer; Andreas Buck; Ralph Naumann; Karoline Spaepen; Rodney J Hicks; Wolfgang A Weber; Sven N Reske; Markus Schwaiger; Lawrence H Schwartz; Josee M Zijlstra; Barry A Siegel; Bruce D Cheson
Journal:  J Clin Oncol       Date:  2007-01-22       Impact factor: 44.544

3.  Histology and time to progression predict survival for lymphoma recurring after reduced-intensity conditioning and allogeneic hematopoietic cell transplantation.

Authors:  Ron Ram; Ted A Gooley; David G Maloney; Oliver W Press; John M Pagel; Stephen H Petersdorf; Andrei R Shustov; Mary E D Flowers; Paul O'Donnell; Brenda M Sandmaier; Rainer F Storb; Ajay K Gopal
Journal:  Biol Blood Marrow Transplant       Date:  2011-04-12       Impact factor: 5.742

4.  Pretransplantation [18-F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transplantation.

Authors:  Anna Dodero; Roberto Crocchiolo; Francesca Patriarca; Rosalba Miceli; Luca Castagna; Fabio Ciceri; Stefania Bramanti; Niccolo Frungillo; Raffaella Milani; Flavio Crippa; Federico Fallanca; Emanuela Englaro; Paolo Corradini
Journal:  Cancer       Date:  2010-11-01       Impact factor: 6.860

5.  Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma.

Authors:  Jonathan R Lambert; Jamshed B Bomanji; Karl S Peggs; Kirsty J Thomson; Ronjon K Chakraverty; Adele K Fielding; Panagiotis D Kottaridis; Michael Roughton; Emma C Morris; Anthony H Goldstone; David C Linch; Peter J Ell; Stephen Mackinnon
Journal:  Blood       Date:  2010-02-02       Impact factor: 22.113

6.  The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT.

Authors:  S P Robinson; C Canals; J J Luang; H Tilly; C Crawley; J Y Cahn; D Pohlreich; S Le Gouill; M Gilleece; N Milpied; M Attal; P Biron; S Maury; A Rambaldi; J Maertens; S Capria; P Colombat; S Montoto; A Sureda
Journal:  Bone Marrow Transplant       Date:  2013-06-17       Impact factor: 5.483

7.  Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

Authors:  Koen van Besien; Fausto R Loberiza; Ruta Bajorunaite; James O Armitage; Asad Bashey; Linda J Burns; Cesar O Freytes; John Gibson; Mary M Horowitz; David J Inwards; David I Marks; Rodrigo Martino; Richard T Maziarz; Arturo Molina; Santiago Pavlovsky; Andrew L Pecora; Harry C Schouten; Thomas C Shea; Hillard M Lazarus; J Douglas Rizzo; Julie M Vose
Journal:  Blood       Date:  2003-07-31       Impact factor: 22.113

8.  Similar and promising outcomes in lymphoma patients treated with myeloablative or nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation.

Authors:  Marcie Tomblyn; Claudio Brunstein; Linda J Burns; Jeffrey S Miller; Margaret MacMillan; Todd E DeFor; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2008-05       Impact factor: 5.742

9.  Pretransplantation fluorine-18-deoxyglucose--positron emission tomography scan lacks prognostic value in chemosensitive B cell non-hodgkin lymphoma patients undergoing nonmyeloablative allogeneic stem cell transplantation.

Authors:  Craig S Sauter; Lauren Lechner; Michael Scordo; Junting Zheng; Sean M Devlin; Stephen E Fleming; Hugo Castro-Malaspina; Craig H Moskowitz
Journal:  Biol Blood Marrow Transplant       Date:  2014-02-15       Impact factor: 5.742

10.  Conventional allogeneic hematopoietic stem cell transplantation for lymphoma may overcome the poor prognosis associated with a positive FDG-PET scan before transplantation.

Authors:  Akihide Yoshimi; Koji Izutsu; Miwako Takahashi; Shinichi Kako; Kumi Oshima; Yoshinobu Kanda; Toru Motokura; Shigeru Chiba; Toshimitsu Momose; Kuni Ohtomo; Mineo Kurokawa
Journal:  Am J Hematol       Date:  2008-06       Impact factor: 10.047
  10 in total
  1 in total

1.  Impact of Pretransplantation (18)F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma.

Authors:  Veronika Bachanova; Linda J Burns; Kwang Woo Ahn; Ginna G Laport; Görgün Akpek; Mohamed A Kharfan-Dabaja; Taiga Nishihori; Edward Agura; Philippe Armand; Samantha M Jaglowski; Mitchell S Cairo; Amanda F Cashen; Jonathon B Cohen; Anita D'Souza; César O Freytes; Robert Peter Gale; Siddhartha Ganguly; Nilanjan Ghosh; Leona A Holmberg; David J Inwards; Abraham S Kanate; Hillard M Lazarus; Adriana K Malone; Reinhold Munker; Alberto Mussetti; Maxim Norkin; Tim D Prestidge; Jacob M Rowe; Prakash Satwani; Tanya Siddiqi; Patrick J Stiff; Basem M William; Baldeep Wirk; David G Maloney; Sonali M Smith; Anna M Sureda; Jeanette Carreras; Mehdi Hamadani
Journal:  Biol Blood Marrow Transplant       Date:  2015-05-14       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.